Related Experiment Video
Updated: Jun 7, 2025

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
Published on: December 16, 2021
Arginine methylation of the p30 C/EBPα oncoprotein regulates progenitor proliferation and myeloid differentiation
Linh T Nguyen1,2, Karin Zimmermann1, Elisabeth Kowenz-Leutz1
1Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Street 10, 13125 Berlin, Germany.
Abstract:
The transcription factor CCAAT enhancer binding protein alpha (C/EBPα) is a master regulator of myelopoiesis. CEBPA encodes a long (p42) and a truncated (p30) protein isoform from a single mRNA. Mutations that abnormally enhance expression of p30 are associated with acute myelogenous leukemia (AML). We show by mutational analysis that three highly conserved arginine residues in the p30 C/EBPα N-terminus, previously found to be methylated, are involved in myeloid lineage commitment, progenitor proliferation, and differentiation. The conservative amino acid substitution with lysine that retains the amino acid side chain charge enhanced progenitor proliferation, while a non-conservative substitution with uncharged side chains (alanine, leucine) impaired proliferation and enhanced granulopoiesis. Analysis of protein interactions suggested that arginine methylation of p30 C/EBPα differentially determines interactions with SWI/SNF and MLL complexes. Pharmacological targeting of p30 C/EBPα arginine methylation may have clinical relevance in myeloproliferative and inflammatory diseases, in neutropenia, and in leukemic stem cells.
Insights
Methylation of arginine residues in the p30 CCAAT enhancer binding protein alpha (C/EBPα) isoform is crucial for myeloid cell development. Targeting this methylation may offer new treatments for myeloid disorders and leukemia.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- CCAAT enhancer binding protein alpha (C/EBPα) is a key regulator of myelopoiesis.
- The truncated p30 C/EBPα isoform, encoded by the CEBPA gene, is implicated in acute myelogenous leukemia (AML) when its expression is abnormally enhanced.
Purpose of the Study:
- To investigate the role of specific arginine residues in the p30 C/EBPα N-terminus in myeloid lineage commitment, progenitor proliferation, and differentiation.
- To explore the impact of arginine methylation on p30 C/EBPα interactions with protein complexes.
Main Methods:
- Mutational analysis of conserved arginine residues in the p30 C/EBPα N-terminus.
- Amino acid substitution experiments (conservative and non-conservative).
- Analysis of protein-protein interactions with SWI/SNF and MLL complexes.
Main Results:
- Conservative substitution of arginine with lysine enhanced progenitor proliferation.
- Non-conservative substitutions with alanine or leucine impaired proliferation but enhanced granulopoiesis.
- Arginine methylation of p30 C/EBPα differentially regulates interactions with SWI/SNF and MLL complexes.
Conclusions:
- Specific arginine residues in p30 C/EBPα are critical for myeloid development.
- Arginine methylation status influences p30 C/EBPα's interaction with key cellular complexes.
- Targeting p30 C/EBPα arginine methylation presents potential therapeutic strategies for myeloid diseases, including AML and inflammatory conditions.
Related Concept Videos
Epigenetic Regulation
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Master Transcription Regulators
Differentiation of Common Myeloid Progenitor Cells
Negative Regulator Molecules

